Undervalued Stocks Based On Cash Flows
Risultati
6
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
6 aziende
| Azienda | Ultimo prezzo | Ritorno 7D | Ritorno a 1 anno | Cap. di mercato | Obiettivo degli analisti | Valutazione | Crescita | Rendimento del dividendo | Industria | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ROVI | €58.55 | -0.4% | 10.2% | €3.0b | €74.36 | 16.2 | 12.2% | 1.6% | Pharmaceuticals & Biotech | ||
BYTE | €5.00 | -2.9% | -18.0% | €149.8m | n/a | 692.1 | 60.9% | n/a | Consumer Services | ||
PANG | €1.55 | 0% | -9.9% | €55.7m | n/a | 3.3 | 96.1% | n/a | Pharmaceuticals & Biotech | ||
TUB | €3.04 | -2.6% | -16.5% | €372.3m | €4.14 | 0.5 | 82.9% | 6.7% | Materials | ||
ACX | €17.38 | -4.6% | 74.8% | €4.3b | €17.84 | 80.1 | 33.9% | 3.6% | Materials | ||
ART | €29.10 | -4.9% | 155.3% | €1.7b | €34.25 | 29.9 | 21.0% | 0.6% | Capital Goods |
Page 1 of 1